256 related articles for article (PubMed ID: 23682851)
1. Epstein-Barr virus-associated smooth muscle tumors after kidney transplantation: treatment and outcomes in a single center.
Tan CS; Loh HL; Foo MW; Choong LH; Wong KS; Kee TY
Clin Transplant; 2013; 27(4):E462-8. PubMed ID: 23682851
[TBL] [Abstract][Full Text] [Related]
2. A rare case of Epstein-Barr virus-associated hepatosplenic smooth muscle tumors after kidney transplantation.
Pircher C; Schneeberger S; Boesmueller C; Agaimy A; Zoller H; Bale R; Henninger B; Mayer G; Neuwirt H
Transpl Infect Dis; 2018 Jun; 20(3):e12860. PubMed ID: 29427352
[TBL] [Abstract][Full Text] [Related]
3. Use of sirolimus for Epstein-Barr virus-positive smooth-muscle tumour.
Toh HC; Teo M; Ong KW; Lee V; Chan E; Lee AS; Vathsala A
Lancet Oncol; 2006 Nov; 7(11):955-7. PubMed ID: 17081922
[No Abstract] [Full Text] [Related]
4. The utilization of sirolimus and the impact on wound-healing complications in obese kidney transplant recipients.
Hulbert AL; Delahunty AJ; Rajab A; Forbes RC; Winters HA
Clin Transplant; 2013; 27(4):E521-7. PubMed ID: 23923974
[TBL] [Abstract][Full Text] [Related]
5. Treatment response with sirolimus for a pediatric patient with an EBV-associated smooth-muscle tumor after bone marrow transplantation.
Penney SW; Bishop BN; Howell DL
Pediatr Blood Cancer; 2019 May; 66(5):e27585. PubMed ID: 30614215
[TBL] [Abstract][Full Text] [Related]
6. Association of Baseline Viral Serology and Sirolimus Regimens With Kidney Transplant Outcomes: A 14-Year Registry-Based Cohort Study in the United States.
Santos AH; Casey MJ; Xuerong W; Womer KL
Transplantation; 2017 Feb; 101(2):377-386. PubMed ID: 28121742
[TBL] [Abstract][Full Text] [Related]
7. Synchronous hepatic, mesenteric and pulmonary Epstein-Barr virus-associated smooth muscle tumors in a renal transplant recipient.
Al Hussain T; Haleem A; Alsaad KO
Clin Transplant; 2010; 24(5):579-84. PubMed ID: 20156224
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus associated smooth muscle tumors in solid organ transplant recipients: Incidence over 31 years at a single institution and review of the literature.
Stubbins RJ; Alami Laroussi N; Peters AC; Urschel S; Dicke F; Lai RL; Zhu J; Mabilangan C; Preiksaitis JK
Transpl Infect Dis; 2019 Feb; 21(1):e13010. PubMed ID: 30298678
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-associated smooth muscle tumors after lung transplantation.
Hirama T; Tikkanen J; Pal P; Cleary S; Binnie M
Transpl Infect Dis; 2019 Jun; 21(3):e13068. PubMed ID: 30864272
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-associated smooth muscle tumors in a composite tissue allograft and a pediatric liver transplant recipient.
Conrad A; Brunet AS; Hervieu V; Chauvet C; Buron F; Collardeau-Frachon S; Rivet C; Cassier P; Testelin S; Lachaux A; Morelon E; Thaunat O
Transpl Infect Dis; 2013 Oct; 15(5):E182-6. PubMed ID: 24034213
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-associated smooth muscle tumor in a kidney transplant recipient: A case-report and review of the literature.
Tardieu L; Meatchi T; Meyer L; Grataloup C; Bernard-Tessier A; Karras A; Thervet E; Lazareth H
Transpl Infect Dis; 2021 Feb; 23(1):e13456. PubMed ID: 32881184
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus load in whole blood is associated with immunosuppression, but not with post-transplant lymphoproliferative disease in stable adult heart transplant patients.
Doesch AO; Konstandin M; Celik S; Kristen A; Frankenstein L; Sack FU; Schnabel P; Schnitzler P; Katus HA; Dengler TJ
Transpl Int; 2008 Oct; 21(10):963-71. PubMed ID: 18564989
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus-associated smooth muscle tumors in children following solid organ transplantation: a review.
Jossen J; Chu J; Hotchkiss H; Wistinghausen B; Iyer K; Magid M; Kamath A; Roayaie S; Arnon R
Pediatr Transplant; 2015 Mar; 19(2):235-43. PubMed ID: 25572657
[TBL] [Abstract][Full Text] [Related]
14. [Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol].
Merlino C; Giacchino F; Bergallo M; Bonello F; Bollero C; Segoloni GP; Cavallo R
G Ital Nefrol; 2003; 20(2):170-5. PubMed ID: 12746803
[TBL] [Abstract][Full Text] [Related]
15. "Epstein-Barr virus associated smooth muscle tumour as an unusual cause of ureteric graft obstruction in a child".
Szklarz MT; Tessi C; Ruiz J; Rosiere NI; Lopez Imizcoz F; Weller S; Solernou VE; Monteverde ML; Corbetta JP
Pediatr Transplant; 2021 Dec; 25(8):e14109. PubMed ID: 34363296
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus & Epstein Barr Virus serostatus as a predictor of the long-term outcome of kidney transplantation.
Le Page AK; Mackie FE; McTaggart SJ; Kennedy SE
Nephrology (Carlton); 2013 Dec; 18(12):813-9. PubMed ID: 23927085
[TBL] [Abstract][Full Text] [Related]
17. [Diffuse lymphoproliferative disease after renal transplantation and its relation with Epstein-Barr virus. Experience at one center].
Franco A; Jiménez L; Aranda I; Alvarez L; González M; Rocamora N; Olivares J
Nefrologia; 2002; 22(5):463-9. PubMed ID: 12497748
[TBL] [Abstract][Full Text] [Related]
18. Better actual 10-year renal transplant outcomes of 80% reduced cyclosporine exposure with sirolimus base therapy compared with full cyclosporine exposure without or with concomittant sirolimus treatment.
Pliszczynski J; Kahan BD
Transplant Proc; 2011 Dec; 43(10):3657-68. PubMed ID: 22172822
[TBL] [Abstract][Full Text] [Related]
19. Expression of EBV latent antigens, mammalian target of rapamycin, and tumor suppression genes in EBV-positive smooth muscle tumors: clinical and therapeutic implications.
Ong KW; Teo M; Lee V; Ong D; Lee A; Tan CS; Vathsala A; Toh HC
Clin Cancer Res; 2009 Sep; 15(17):5350-8. PubMed ID: 19706821
[TBL] [Abstract][Full Text] [Related]
20. Everolimus leads to a lower risk of BKV viremia than mycophenolic acid in de novo renal transplantation patients: a single-center experience.
Moscarelli L; Caroti L; Antognoli G; Zanazzi M; Di Maria L; Carta P; Minetti E
Clin Transplant; 2013; 27(4):546-54. PubMed ID: 23758330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
